Unknown NA INTERVENTIONAL 1-arm NCT03414944

Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases (SMART-Brain)

Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases,A Phase I,One-arm Trial

Sponsor: Qilu Hospital of Shandong University

Conditions Brain Metastases

Interventions SMART-Brain

Updated 6 times since 2018 Last updated: Jan 29, 2018 Started: Dec 2, 2016 Primary completion: May 30, 2018 Completion: Sep 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03414944, this NA trial focuses on Brain Metastases and remains ongoing. Sponsored by Qilu Hospital of Shandong University, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2020 [monthly]

Recruiting NA

▶ Show 1 earlier version

Feb 2018 — Jun 2018 [monthly]

Recruiting NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Qilu Hospital of Shandong University
Shandong Cancer Hospital and Institute
Shandong Provincial Hospital
The Affiliated Hospital of Xuzhou Medical University

Data source: Shandong Cancer Hospital and Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jin'an, China